Monogram Orthopaedics (NASDAQ:MGRM) Releases Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Monogram Orthopaedics (NASDAQ:MGRM) issued its earnings results on Wednesday. The company reported ($0.08) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.03, Zacks reports.

Monogram Orthopaedics Stock Performance

Shares of MGRM opened at $2.31 on Friday. The stock has a market capitalization of $79.26 million, a PE ratio of -4.91 and a beta of 1.66. The company’s fifty day moving average is $2.54 and its 200 day moving average is $2.50. Monogram Orthopaedics has a fifty-two week low of $1.53 and a fifty-two week high of $4.90.

Analyst Upgrades and Downgrades

MGRM has been the topic of several research analyst reports. Roth Mkm began coverage on shares of Monogram Orthopaedics in a research note on Monday, December 9th. They issued a “buy” rating and a $4.00 price target on the stock. Roth Capital upgraded Monogram Orthopaedics to a “strong-buy” rating in a research report on Monday, December 9th.

Monogram Orthopaedics Company Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.